CAMP4 Therapeutics Corpor... (CAMP)

NASDAQ: CAMP · Real-Time Price · USD

1.80

0.03 (1.69%)

At close: May 01, 2025, 3:59 PM

1.97

9.14%

After-hours: May 01, 2025, 04:18 PM EDT

CAMP4 Therapeutics Income Statement

Financials in USD. Fiscal year is March - February.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Nov 30, 2023	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021	Feb 29, 2020	Feb 28, 2019	Feb 28, 2018	Feb 28, 2017	Feb 29, 2016
Revenue	186.23M	294.95M	295.84M	308.59M	366.11M	363.8M	365.91M	351.1M	280.72M
Cost of Revenue	119.25M	185.94M	173.95M	186.18M	222.8M	216.04M	215.02M	207.75M	177.76M
Gross Profit	66.98M	109.01M	121.89M	122.41M	143.3M	147.76M	150.89M	143.35M	102.96M
Operating Income	-8.72M	-21.48M	-15.31M	-3.87M	-16.77M	19.7M	7.96M	1.34M	28.09M
Interest Income	2.81M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-92.74M	-31.34M	-30.06M	-20.6M	-58.32M	23.86M	28.71M	-6.96M	22.34M
Net Income	-93.26M	-32.49M	-31.15M	-21.16M	-78.77M	18.4M	16.62M	-7.15M	16.94M
Selling & General & Admin	61.01M	99.21M	100.9M	95.28M	118.2M	80.96M	102.19M	104.94M	48.45M
Research & Development	14.69M	24.57M	28.44M	25.81M	29.44M	27.66M	25.76M	22M	19.8M
Other Expenses	n/a	5.33M	5.42M	4.78M	12.32M	-672K	445K	-101K	-20K
Operating Expenses	75.7M	129.11M	134.76M	125.87M	159.96M	120.05M	142.94M	142.01M	74.87M
Interest Expense	n/a	6.26M	15.32M	15.49M	20.1M	16.73M	10.28M	9.9M	7.59M
Selling & Marketing Expenses	29.52M	47.39M	48.56M	46.2M	60.53M	49.89M	50.1M	49.04M	23.38M
Cost & Expenses	194.95M	315.05M	308.71M	312.05M	382.76M	336.09M	357.96M	349.76M	252.63M
Income Tax Expense	-525K	1.15M	1.09M	561K	20.45M	-1.33M	10.68M	-1.1M	4.57M
Shares Outstanding (Basic)	37.02M	36.1M	35.25M	34.12M	33.48M	34.59M	35.25M	35.92M	36.45M
Shares Outstanding (Diluted)	37.02M	36.13M	35.25M	34.39M	33.67M	35.29M	36.14M	35.92M	36.95M
EPS (Basic)	-2.52	-0.9	-0.88	-0.62	-2.34	0.53	0.47	-0.2	0.46
EPS (Diluted)	-2.52	-0.9	-0.88	-0.62	-2.34	0.52	0.46	-0.2	0.46
EBITDA	-8.72M	276K	7.49M	18.13M	15.22M	47.05M	31.36M	24.71M	38.27M
EBIT	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	n/a	21.76M	22.8M	22M	31.99M	20.02M	22.96M	23.47M	10.21M